DEA Accused of Bias Against Marijuana Rescheduling Amid Controversial Hearings
New claims have surfaced accusing the Drug Enforcement Administration (DEA) of undermining a proposed shift in federal marijuana policy. Attorneys for cannabis advocacy groups argue that the agency's actions suggest…